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Abstract:  
Hepatocellular carcinoma (HCC) is an aggressive subtype of liver cancer with few effective 
treatments and the underlying mechanisms that drive HCC pathogenesis remain poorly 
characterized. Identifying genes and pathways essential for HCC cell growth will aid the 
development of new targeted therapies for HCC. Using a kinome CRISPR screen in three 
human HCC cell lines, we identified transformation/transcription domain-associated protein 
(TRRAP) as an essential gene for HCC cell proliferation. TRRAP has been implicated in 
oncogenic transformation, but how it functions in cancer cell proliferation is not established. 
Here, we show that depletion of TRRAP or its co-factor, histone acetyltransferase KAT5, 
inhibits HCC cell growth via induction of p53- and p21-independent senescence. Integrated 
cancer genomics analyses using patient data and RNA-sequencing identified mitotic genes 
as key TRRAP/KAT5 targets in HCC, and subsequent cell cycle analyses revealed that 
TRRAP- and KAT5-depleted cells are arrested at G2/M phase. Depletion of TOP2A, a 
mitotic gene and TRRAP/KAT5 target, was sufficient to recapitulate the senescent 
phenotype of TRRAP/KAT5 knockdown.  
Conclusion: Our results uncover a role for TRRAP/KAT5 in promoting HCC cell proliferation 
via activation of mitotic genes. Targeting the TRRAP/KAT5 complex is a potential 
therapeutic strategy for HCC. 
 
Liver cancer accounts for more than 27,000 deaths in the United States and more than 
700,000 deaths worldwide each year (1, 2). The 5-year survival rate for liver cancer patients 
is 18% and the major subtype of liver cancer is hepatocellular carcinoma (HCC) (3). Current 
approved advanced HCC treatments include multi-kinase inhibitors regorafenib, lenvatinib 
and sorafenib, which extend patient survival by several months only, and the immune 
checkpoint inhibitors Nivolumab and Pembrolizumab, which show ~20% response rates as a 
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unmet partially because HCC is genetically heterogeneous and because HCC driver genes 
amenable to targeted therapy are largely unknown (1, 4). Identifying genes whose depletion 
can inhibit HCC growth, and determining the mechanisms involved, will aid the development 
of targeted therapies for HCC patients.  
 
Using a kinome CRISPR screen in three HCC cell lines, we identified transformation/ 
transcription domain-associated protein (TRRAP) as the top-ranking candidate gene 
required for HCC cell growth. TRRAP, a pseudokinase member of the PI3 kinase-like family, 
acts as a scaffold protein in histone acetyltransferase (HAT) complexes (5-7) that regulate 
transcription, DNA repair, and replication (8). TRRAP is also a key regulator of cell cycle 
progression and stemness in embryonic stem cells and cortical apical neural progenitors (9, 
10). 
 
TRRAP is mutated and amplified in different cancer types, including melanomas, gastric, 
and uterine cancers (11-14), and has been implicated in oncogenic transformation. Indeed, 
the TRRAP S722F hotspot mutation in melanomas can transform NIH3T3 cells (11). 
Moreover, wildtype TRRAP is required for transformation by c-myc/Hras and E1A/Hras in rat 
embryo fibroblasts (15) and MYC-dependent tumor initiation in a breast cancer model (16). 
By contrast, depletion of TRRAP can induce apoptosis and differentiation in lymphoma and 
brain-tumor initiating cells (17, 18). Given its role in diverse cellular processes, it is possible 
that TRRAP and its regulated pathways are altered in cancer. However, the extent of 
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Here, we show that depletion of TRRAP/KAT5 in HCC cells induces G2/M arrest and 
senescence in a p53- and p21-independent manner. We found that TRRAP/KAT5 activates 
a subset of mitotic genes that is highly expressed in HCC and is associated with poor 
survival in HCC patients. Depletion of TOP2A, a mitotic gene and TRRAP/KAT5 target, is 
sufficient to recapitulate the senescent phenotype observed in TRRAP- and KAT5-depleted 
cells. Together, our study uncover a role for TRRAP/KAT5 in HCC cell growth and disruption 
of TRRAP/KAT5 is a potential therapeutic strategy for HCC.  
 
Materials and Methods 
Cell culture 
Huh7 and SNU475 cells were provided by Dr. Scott Lowe. Huh7 cells were cultured in 
DMEM. SNU-475 cells were cultured in RPMI supplemented with 10 mM HEPES, 1 mM 
sodium pyruvate, and 4500 mg/L glucose. Hep3B and HepG2 cells were provided by Dr. 
Junwei Shi and cultured in MEM. All cell lines were grown in media supplemented with 10% 
FBS and 1% penicillin-streptomycin and maintained in a 37C incubator with 5% CO2. Huh7, 
HepG2, Hep3B and SNU-475 cells were authenticated using ATCC’s cell authentication 
service. MG132 and chloroquine were purchased from Millipore Sigma.  
 
Kinome CRISPR screen  
The human kinome CRISPR pooled library was a gift from John Doench and David Root 
(Addgene #1000000083). The library was amplified according to Addgene’s library 
amplification protocol. Lentivirus containing the kinome library was packaged using 293fs 
cells. For each cell line, duplicates were performed. For each replicate, 2 × 107 cells were 
infected with lentivirus. Huh7 and Hep3B cells were selected with 2 µg/mL puromycin for 3 
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genomic DNA was harvested from at least 6 × 106 cells using the PureLink Genomic DNA 
mini kit (Thermo Fisher Scientific, Waltham, MA). sgRNA was amplified using Phusion flash 
high-fidelity PCR master mix (Thermo Fisher Scientific). All sequencing datasets were 
evaluated using FastQC (version 0.11.2) to ensure high quality. Depleted genes were 
identified as previously described (19). 
 
Bioinformatics analysis  
To analyze gene expression levels between tumor and non-tumor tissues, the GSE14520 
(20) and TCGA HCC data sets were used. Gene expression data of tumor (n=225) and non-
tumor tissue (n=220) in the GSE14520 data set were analyzed using GEO2R 
(https://www.ncbi.nlm.nih.gov/geo/geo2r/). Briefly, P-values were calculated using 
moderated t-statistics and adjusted using the Benjamini-Hochberg method. Gene expression 
data of TCGA HCC tumors and matched non-tumors (n=50) were obtained from the UCSC 
Xena Browser (http://xena.ucsc.edu/) and analyzed using the Wilcoxon signed-rank test. The 
list of genes that predict prognosis of HCC patients was obtained from the Human Protein 
Atlas (version 18, https://www.proteinatlas.org/) . For survival analysis, FKPM values and 
survival data were obtained from the Human Protein Atlas and cBioPortal 
(http://www.cbioportal.org/) respectively. The LEC data is available on GEO with accession 
numbers GSE1898 and GSE4024 (21, 22). FKPM values were grouped in tertiles and the 
highest and lowest tertiles were designated as ‘high expression’ and ‘low expression’ 
groups. P-values were calculated using the log-rank Mantel-Cox test with GraphPad Prism. 
TRRAP mutations and copy-number alterations in HCC were obtained from cBioPortal. For 
gene correlation analyses, correlation data from the TCGA HCC (n=360) and GBM (n=136) 
data sets were obtained from cBioPortal. Briefly, gene expression data were analyzed using 
Spearman’s correlation analysis. For GO analyses, the list of genes was analyzed using the 
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2018-10-08). P-values were calculated using Fisher’s Exact test and corrected by the 
Benjamini-Hochberg method. To determine KAT5 binding sites, we analyzed ChIP-
sequencing data from GSE69671 (23). 
 
sgRNA design and lentivirus infection 
sgRNAs were designed using https://portals.broadinstitute.org/gpp/public/analysis-
tools/sgrna-design, cloned into the LentiCRISPRv2 backbone (Addgene #52961) and 
packaged into lentivirus using 293fs cells. HCC cells infected with lentivirus were selected 
with puromycin for 2-4 days. To generate double sgRNA-infected cells, sgNT and sgp21 
were cloned into the LentiCRISPRv2 hygro backbone (Addgene #98291). SNU-475 and 
Huh7 cells infected with lentivirus were selected with 100 and 500 µg/mL hygromycin for 6 
and 10 days respectively, then infected with sgNT, sgTRRAP, sgKAT5, and sgKAT2A, and 
selected with puromycin. Sequences of sgRNAs are listed in Supplementary Table 1.  
 
Immunoblot Analysis  
Cells were washed twice with ice-cold PBS and harvested in RIPA buffer (Boston 
Bioproducts, Ashland MA) supplemented with protease (Roche, Indianapolis, IN) and 
phosphatase inhibitor cocktails (Thermo Fisher Scientific). The concentration of protein was 
measured using the BCA assay (Thermo Fisher Scientific). For each sample, 25 µg of 
protein was loaded onto an SDS-PAGE gel. The following antibodies were used to probe 
against: TRRAP (#3967; Cell Signaling Technology, Danvers, MA), p21 (#2947; Cell 
Signaling Technology), KAT2A (#3305; Cell Signaling Technology), KAT5 (sc-166323; 
Santa-Cruz Biotechnology, Dallas, TX), NIK (#4994; Cell Signaling Technology), LC3B 
(#2775; Cell Signaling Technology), TOP2A (#12286; Cell Signaling Technology), p53 (sc-
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(#610419; BD Bioscience, San Jose, CA), and Flag (#2368; Cell Signaling Technology and 
#F1804; Millipore Sigma). Bands were visualized with an immunofluorescent secondary 
antibody (LICOR) using the Odyssey Imaging system.   
 
Cell growth and colony formation assays  
To measure cell growth, cells were seeded onto 96-well plates. CellTitre-glo assay 
(Promega, Madison, WI) was performed according to the manufacturer’s protocol. The 
growth of cells at day 3 and day 5 was normalized to measurements taken one day after the 
cells were plated. Each repeat was averaged between 6 wells. For colony formation assays, 
Huh7 and SNU-475 cells were seeded at 3000 and 2000 cells per well respectively onto 6-
well plates. After 11 days, cells were fixed with 4% formalin and stained with 0.5% crystal 
violet. All experiments were repeated three times.  
 
SA-β-gal assay 
Huh7, Hep3B, and SNU-475 cells were seeded onto 12-well plates, senescence-associated 
β-galactosidase (SA-β-gal) staining was performed at pH = 6.0 and positively stained cells 
were quantified as previously described (24).  
 
RNA extraction and RT-qPCR  
RNA was extracted from cells using the RNeasy mini kit (Qiagen, Germantown, MD) and 
DNA was removed by on-column DNase digestion (Qiagen) according to the manufacturer’s 
protocol. One microgram of RNA was used to synthesize cDNA using the high-capacity 
cDNA reverse transcription kit (Thermo Fisher Scientific) according to the manufacturer’s 
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Hercules, CA) according to the manufacturer’s protocol and GAPDH was used as a control. 
Primer sequences used for qRT-PCR are listed in Supplementary Table 2.  
 
Xenografts in nude mice 
Female 6-week-old NCRNu/Nu mice were purchased from Taconic Bioscience (Rensselaer, 
NY) and injected in the right or left flank with 1x106 TRRAP stable knockdown Huh7 cells. 
Cells were resuspended in PBS and mixed in a 2:1 ratio with matrigel (Westnet Inc., Canton, 
MA) to a final volume of 200 L. Tumor size was measured by calipers and volume was 
calculated using the formula        
                   
 
.  All mice were housed in JAG75 
(Allentown) ventilated cage systems with 1/4″ Bed-o’Cobs (Andersons Lab Bedding) in 
facilities accredited by the American Association for Laboratory Animal Care (AALAC) at the 
University of Massachusetts (UMass) Medical School. Mice were provided with nestlets 
(Ancare) and Bed-r’Nests (Andersons Lab Bedding) and maintained in a pathogen‐free 
animal facility at 22°C under the 12‐hour light/dark cycle. Mice were injected during the light 
cycle and were not fasted prior to injection. Mice were maintained on a standard diet of 
Prolab Isopro RMH 3000 (LabDiet) throughout the course of the experiment. All animal 
protocols were approved by the UMass Medical School Institutional Animal Care and Use 
Committee (IACUC) and comply with all relevant federal guidelines and institutional policies.   
 
RNA-sequencing and bioinformatics analysis  
Ribosomal RNA was depleted and RNA-sequencing libraries were prepared as previously 
described (25). The libraries were quantified using the KAPA Library Quantification Kit (Kapa 
Biosystems, Wilmington, MA) and sequenced using the Illumina NextSeq 500 system. RNA-
seq reads from each sample were aligned using STAR (version 2.5.2b) (26) against the 
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(v1.2.31) (27) with GENCODE V19 gene annotation. DESeq2 (1.22.0) (28) was employed to 
identify differentially expressed genes using raw read counts quantified by htseq-count (29). 
 
Flow cytometry analyses  
For cell cycle analysis, Huh7 and SNU-475 cells were pulsed with 30 µg/mL 5-Bromo-2´-
Deoxyuridine (BrdU, Thermo Fisher Scientific) for 1 hour at 37C. Cells were then 
trypsinized and fixed with 70% ethanol, permeabilized with 0.3% Triton-X 100 and incubated 
with a BrdU-FITC conjugated antibody (Thermo Fisher Scientific). Cells were stained with 50 
ng/mL propidium iodide (Thermo Fisher Scientific), 10 g/mL RNase A (Thermo Fisher 
Scientific), and incubated for 30 minutes at 37C. For H2AX analysis, cells were fixed in 
70% ethanol, permeabilized with 0.3% Triton-X100 and blocked in 0.8% BSA. Cells were 
then incubated with an anti-γH2A.X antibody (#9718; Cell Signaling Technology), which was 
detected using a mouse-FITC IgG. Cells were also stained with propidium iodide as 
described above to identify 2N and >2N populations. For each sample, at least 40,000 cells 
were analyzed using the MACSQuant VYB Flow cytometer (MACS Miltenyi Biotec, Auburn, 
CA). All data were analyzed by FlowJo 10.0 software.   
 
Statistics 
Statistical analysis was performed using GraphPad Prism software and data were presented 
as means  standard deviation. Student’s t-test was used to determine P-values unless 
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Results  
A kinome CRISPR screen identifies TRRAP as a regulator of cell growth in 
HCC  
To identify genes that are required for cell growth in HCC, we infected three HCC cell lines 
(Huh7, HepG2, and Hep3B) with a kinome CRISPR library that targets 763 kinases with 8 
single guide RNAs (sgRNAs) per gene. To determine changes in sgRNA representation, we 
harvested genomic DNA from cells of an early passage and after 10 passages, then 
amplified and identified sgRNAs using PCR and deep sequencing, respectively. We found 
that 31 genes were significantly depleted in all three HCC cell lines (Figure 1A). Among 
these 31 genes, 8 genes (AURKB, BUB1B, CDC7, DTYMK, PGK1, TPR, TRRAP, VRK1) 
were expressed at least 1.5-fold higher in HCC compared to non-tumor tissue (Figure 1B, 
1C, and Supplementary Figure 1A). High expression levels of these genes were associated 
with poor survival in HCC patients (Figure 1D and Supplementary Figure 1B). Of note, 
previous studies have shown that AURKB, DTYMK, PGK1, TPR, and VRK1 promote HCC 
tumorigenesis (30-34). 
 
Out of the 8 genes, TRRAP is the top depleted gene in all three cell lines (Figure 1B). 
Analysis of the TCGA data set revealed that 12% of HCC patient samples have increased 
TRRAP mRNA expression, amplification and/or mutations in the TRRAP gene 
(Supplementary Figure 1C). Using additional published patient data sets, we confirmed that 
TRRAP expression is higher in tumor compared to matched normal tissue (Figure 1C), and 
increased TRRAP expression is correlated with poor survival (Figure 1D). We also 
investigated whether TRRAP expression is correlated with certain gene signatures in HCC. 
We performed Ingenuity pathway analysis and found that TRRAP expression is positively 
correlated with expression of genes that are involved in ‘molecular mechanisms of cancer’, 
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(Supplementary Figure 1D). These results suggest that TRRAP may have an oncogenic role 
in HCC. 
 
Depletion of TRRAP induces senescence in HCC cells 
To understand the function of TRRAP in HCC, we depleted TRRAP expression in Huh7 
Hep3B and SNU-475 cells using CRISPR (sgTRRAP) (Figure 2A). Loss of TRRAP resulted 
in decreased cell growth and colony formation in these cell lines (Figure 2B and 2C). 
Morphologically, the cells became flatter and enlarged after TRRAP depletion, reminiscent of 
a senescent phenotype (35). Indeed, loss of TRRAP in Huh7 and Hep3B cells resulted in 
positive senescence-associated-beta-galactosidase (SA-β-gal) staining (Figure 2C) (35, 36). 
Furthermore, the molecular markers of senescence—p15, p16, and p21 (35, 36)—were 
increased in sgTRRAP cells compared to non-targeting controls (Figure 2A and 2D). 
Collectively, these data suggest that loss of TRRAP inhibits cell growth by inducing 
senescence.   
 
Histone acetyltransferase KAT5 is required for cell growth in HCC  
TRRAP is an adaptor protein in several HAT complexes. In mammalian cells, TRRAP 
predominantly binds to KAT2A and KAT5 (5-7). We found that TRRAP and KAT5 co-
localized to the nucleus in Huh7 and SNU-475 cells (Supplementary Figure 2A). We found 
that TRRAP depletion resulted in decreased KAT5 and KAT2A expression at the protein, but 
not mRNA level, in Huh7 and SNU-475 cells (Figure 3A and Supplementary Figure 2B). To 
investigate whether KAT2A and KAT5 protein become unstable due to increased protein 
degradation in the absence of TRRAP, we inhibited proteasomal and lysosomal protein 
degradation in sgTRRAP cells with MG132 and chloroquine respectively. However, we found 
that MG132 and chloroquine could not rescue KAT2A and KAT5 protein expression in 
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mechanism. To determine whether TRRAP depletion induces senescence due to loss of 
KAT2A or KAT5 expression, we depleted KAT2A and KAT5 using CRISPR (sgKAT2A and 
sgKAT5) in Huh7 and SNU-475 cells (Figure 3B and Supplementary Figure 2D). We found 
that depletion of KAT5, but not KAT2A, reduced cell growth and colony formation, and 
induced senescence similarly to TRRAP-depleted cells (Figure 3C, 3D, and Supplementary 
Figure 2E). We also found a higher increase in p15 and p21 expression in sgKAT5 cells 
compared to non-targeting control and sgKAT2A cells (Figure 3E and Supplementary Figure 
2F).  
 
To investigate whether depletion of TRRAP, KAT2A, and KAT5 affect tumor growth in vivo, 
we injected nude mice subcutaneously with Huh7 cells expressing sgTRRAP, sgKAT2A, or 
sgKAT5. TRRAP- and KAT5-depleted tumors were significantly smaller than tumors in non-
targeting controls. However, KAT2A depletion did not have any effect on tumor size at the 
end point of the study (Figure 3F). Together, these results suggest that TRRAP depletion 
leads to decreased KAT2A and KAT5 expression, but only KAT5 is required for HCC growth. 
 
p53 and p21 are dispensable for senescence induced by loss of TRRAP and KAT5  
Senescence can be triggered by multiple stimuli, such as DNA damage, replicative stress, 
activation of oncogenes, and oxidative stress (37). A key molecular event in induction of 
senescence is p53 activation (38). However, Huh7 and SNU-475 cells are p53-mutant,  and 
Hep3B cells are p53-null, suggesting that the observed induction of senescence due to 
depleted TRRAP and KAT5 is independent of p53. Since we observed an increase in the 
expression of p21, a p53 target that is also important in inducing senescence (38), we asked 
whether p21 is required to induce senescence in TRRAP- and KAT5-depleted cells. To this 
end, we co-depleted p21 and either TRRAP or KAT5 using CRISPR in Huh7 and SNU-475 
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inhibited colony formation and induced senescence (Figure 4B and 4C), suggesting that the 
canonical p53/p21 pathway is not required for senescence in this context.  
 
TRRAP and KAT5 activate transcription of mitotic genes  
The function of TRRAP in transcriptional regulation has been well described (8). To identify 
genes that are regulated by TRRAP to promote HCC cell growth, we performed RNA-
sequencing in sgTRRAP Huh7 cells to identify differentially-expressed genes. Gene ontology 
(GO) analysis of genes that were down-regulated in sgTRRAP cells were enriched in cell 
cycle processes, including mitosis, chromosome segregation, and cell division (Figure 5A). 
Genes that were up-regulated in sgTRRAP cells were enriched in nucleic acid processing 
(Supplementary Figure 3A).  
 
Next, we cross referenced our RNA-sequencing results with published data sets to identify 
candidate genes that are activated by TRRAP in HCC. We looked for genes that: (1) were 
down-regulated in sgTRRAP cells from our RNA-sequencing data (fold change<0.5), (2) 
were positively correlated with TRRAP expression in the TCGA HCC data set (Spearman’s 
correlation0.3), (3) were overexpressed in HCC compared to non-tumor tissue in the 
GSE14520 data set (fold change2), and 4) predict poor survival in HCC patients when 
highly expressed. We also performed this analysis in the opposite direction to identify genes 
that were repressed by TRRAP (Figure 5B). Using these criteria, we identified 22 HCC-
relevant genes that were activated and 3 that were repressed by TRRAP (Table 1, 
Supplementary Table 3, Supplementary Figures 3B, 3C, 4 and 5). The 3 TRRAP-repressed 
genes (BAAT, ITIH1 and RDH16) were liver specific, whereas 19 of the 22 TRRAP-activated 
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We focused on TRRAP-activated genes for further analysis as they might be potential 
targets for inhibiting HCC growth. To assess whether TRRAP may regulate the same genes 
in another cancer type, we analyzed gene expression data from the TCGA glioblastoma 
multiforme (GBM) data set. TRRAP is required for restricting differentiation of brain tumor-
initiating cells that were derived from human GBM samples (10). We found that 14 of the 22 
genes activated by TRRAP in HCC were positively correlated with TRRAP expression in 
GBM (Spearman’s correlation0.3, Supplementary Table 4), suggesting that TRRAP 
regulates a similar set of genes in both cancer types.  
 
Since TRRAP- and KAT5-depleted cells display a similar senescent phenotype, we asked 
whether TRRAP target genes were also regulated by KAT5. We analyzed previously 
published ChIP-sequencing data in mouse embryonic stem cells for KAT5 binding sites (23) 
and found that KAT5 binds to the transcriptional start sites of 19/22 genes activated by 
TRRAP (Figure 5D and Supplementary Figure 6). After validating our RNA-sequencing data 
by confirming the downregulation of 6 genes after TRRAP depletion using qRT-PCR (Figure 
5E and Supplementary Figure 7A), we investigated the effect of KAT5 and KAT2A depletion 
on the expression of TRRAP target genes. We found that mRNA expression of TRRAP-
activated genes were downregulated in sgKAT5 cells, but not in sgKAT2A cells (Figure 5E 
and Supplementary Figure 7A). In summary, TRRAP and KAT5 are required for 
transcriptional activation of mitotic genes. In HCC, these genes are clinically relevant since 
they are overexpressed and confer poor survival to patients.  
 
TRRAP and KAT5 depletion induces G2/M arrest 
Previous studies have found that cells undergoing oncogene-induced senescence are 
arrested at G1 phase (24), but more recent evidence suggests that G2 arrest can also 
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mitosis, we reasoned that TRRAP depletion may cause alterations in cell cycle progression. 
We analyzed cell cycle profiles using BrdU and PI staining and found that sgTRRAP and 
sgKAT5 cells accumulated at the G2/M phase. As expected, sgKAT2A cells did not 
accumulate at G2/M phase and displayed a cell cycle profile similar to non-targeting controls 
(Figure 5F and Supplementary Figure 7B). We also measured DNA damage using the 
H2AX marker in sgTRRAP, sgKAT2A, and sgKAT5 cells, and found similar levels 
compared to non-targeting controls (Supplementary Figures 7C and 7D). This suggests that 
DNA damage is unlikely the reason for G2/M arrest and senescence upon TRRAP and 
KAT5 depletion. 
 
Depletion of TOP2A is sufficient to recapitulate the senescent phenotype of TRRAP-
depleted cells 
Based on our RNA-sequencing and bioinformatic analyses, we hypothesized that TRRAP 
depletion induces senescence by down-regulating mitotic genes. To investigate this, we 
focused on a downstream target of TRRAP and KAT5—Topoisomerase II alpha (TOP2A) 
(Table 1). TOP2A is highly expressed at G2/M phase and a key regulator of DNA 
decatenation during mitosis (40). We found that TOP2A expression was positively correlated 
to TRRAP expression in HCC and GBM patient samples (Figure 6A and Supplementary 
Figure 8A). Moreover, TOP2A was overexpressed in HCC compared to non-tumor tissue, 
and its increased expression was associated with poor survival in HCC patients (Figure 6A). 
We confirmed that TRRAP and KAT5 depletion reduced TOP2A at the mRNA and protein 
level (Figures 5E, 6B, Supplementary Figures 7A and 9A). Analysis of published ChIP-
sequencing data (23) revealed that KAT5 binding to the transcriptional start site of TOP2A 
(Figure 5D). Using the ChIP-sequencing data, we predicted the KAT5 binding site in the 
human TOP2A promoter. We cloned a 500 bp (-133/+367) and 1 kb (-383/+617) region 
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that overexpression of TRRAP and KAT5 induced TOP2A promoter activity (Supplementary 
Figure 9B). Next, we depleted TOP2A with CRISPR (sgTOP2A) and found reduced colony 
formation, induction of senescence, and G2/M arrest (Figures 6B-E and Supplementary 
Figures 9C-E), phenotypes resembling those of TRRAP or KAT5 depletion. Furthermore, we 
found that H2AX levels in sgTOP2A cells were similar to non-targeting controls, suggesting 
that DNA damage is not the cause for the observed G2/M arrest and senescence 
(Supplementary Figure 9F). Together, our results suggest that TOP2A is a key mitotic target 
of TRRAP and KAT5 in regulating HCC cell growth. 
 
Discussion 
Here, we demonstrate that TRRAP functions in HCC cell proliferation by promoting G2/M 
progression. TRRAP depletion led to cell cycle arrest at G2/M phase and induction of 
senescence (Figure 6F). Previous studies in other cell types have identified several cell 
cycle genes that are regulated by TRRAP, including cyclins A2, D1, D2 and E, Mad1, Mad2, 
and MKI67 (17, 41-43). We found that the majority of TRRAP-activated genes in HCC are 
involved in mitosis, and include genes not previously known to be TRRAP targets. 
Transcriptional activation of TRRAP-activated genes also required KAT5, indicating a 
specificity in recruitment of chromatin factors by TRRAP. Other TRRAP-interacting 
transcription factors, such as Myc and β-catenin, are frequently altered in HCC (8, 44). 
Investigations into whether these factors are important for TRRAP-dependent cell cycle 
control in HCC are warranted.   
 
The oncogenic roles of G2/M genes in tumorigenesis have been reported. Over-expression 
of genes that regulate DNA replication and chromosomal segregation are involved in 
promoting chromosomal instability, a phenotype of aggressive cancers (45). In liver cancer, 
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(46). Of note, our study has identified FOXM1 is one of the TRRAP-activated genes. We 
also found that 11 of our 22 TRRAP-activated genes overlapped with the chromosomal 
instability gene signature (45). Thus, TRRAP overexpression may contribute to 
chromosomal instability in HCC.  
 
The function of TRRAP in other cancer types is unclear. A previous study found that TRRAP 
depletion induces differentiation of brain tumor-initiating cells derived from GBM patients, 
partially due to reduced cyclin A2 expression and S/G2 progression (17). We found that 
cyclin A2 is also a TRRAP-activated gene in HCC, although we did not observe a strong 
positive correlation between cyclin A2 and TRRAP mRNA expression in TCGA GBM patient 
samples. However, we found an overlap in TRRAP-activated genes (14 of the 22) between 
GBM and HCC. Thus, TRRAP may regulate a similar set of genes between different cancer 
types. However, unlike in HCC, TRRAP mRNA expression is not a prognostic predictor in 
either GBM or other cancers (Supplementary Figure 8B and based on data from the Human 
protein atlas). TRRAP mutations are reported in several cancer types, but their effects have 
not been studied.  
 
Generally, p53 activation is a key event in senescence, but we discovered that TRRAP 
depletion induces senescence independent of the p53/p21 pathway in HCC cells. This 
finding has clinical implications for HCC treatment as 30% of HCC patients has p53 
mutations (44) and p53 is more frequently mutated in HCC patients with high TRRAP 
expression (Supplementary Figure 10). A p53- and p21-independent mechanism in 
immortalized human diploid fibroblasts has been described (47). In this previous study, loss 
of the histone acetyltransferase p300 induced senescence due to global H3 and H4 
hypoacetylation and subsequent alterations in DNA replication timing and fork velocity (47). 
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senescence due to downregulation of mitotic genes, such as TOP2A, and G2/M arrest. Our 
mechanism identifies the TRRAP complex as a potential therapeutic target in HCC. Given 
that the crystal structure of the TRRAP/KAT5 complex was recently characterized in yeast, it 
may be possible to target the interaction between TRRAP and KAT5 and disrupt the histone 
acetyltransferase activity of the complex (48). Moreover, small molecule inhibitors targeting 
KAT5 and mitotic proteins are currently under development (49, 50). Taken together, 
targeting the TRRAP/KAT5 complex or its downstream mitotic genes may be a pro-
senescent strategy for treating HCC patients. 
 
Our results provide an important discovery for a role for TRRAP and its co-factor KAT5 in 
activating downstream mitotic genes in HCC cell growth. Future work should determine how 
TRRAP overexpression and mutations affect its function to understand the extent and 
significance of TRRAP alterations in other cancers. Moreover, because in vivo models of 
TRRAP consist of only genetic knockouts, it will be critical to establish constitutively-active 
TRRAP and mutant TRRAP models to further characterize its role in tumor development. 
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Figure Legends 
Figure 1. A kinome CRISPR screen identifies TRRAP as an essential gene for HCC cell 
growth. A) Three HCC cell lines were used to identify genes whose depletion inhibit HCC 
proliferation. Eight candidate genes were identified by integrating CRISPR screen results 
with HCC patient data. B) Genes from the CRISPR screen were ranked by their false 
discovery rate, the 8 candidate genes are indicated. C) mRNA levels of TRRAP in non-tumor 
and tumor samples from the GSE14520 (left) and TCGA (right) data sets, p-values were 
calculated using moderated t-test and Wilcoxon signed-rank test respectively. Black lines 
indicate the geometric mean of each group. D) Kaplan Meier curves of HCC patients from 
the TCGA (left) and NIH Laboratory of Experiment Carcinogenesis (LEC, right) cohorts with 
high (TCGA n=115 and LEC n=31) or low (TCGA n=118 and LEC n=31) TRRAP expression. 
P-values were calculated using the log-rank Mantel-Cox test. *p < 0.05, ***p < 0.001.  
 
Figure 2. Loss of TRRAP impairs cell growth and induces senescence in HCC cells. A) 
TRRAP and p21 protein expression in Huh7, Hep3B, and SNU-475 cells infected with non-
target (sgNT) and 3 individual TRRAP sgRNAs (sgTRRAP). B and C) Cell growth, colony 
formation and induction of senescence of Huh7, Hep3B, and SNU-475 cells infected with 
sgNT and sgTRRAP. B) Cell growth was measured at 1, 3, and 5 days after plating using 
the CTG assay and normalized to day 1. C) Cells were stained with crystal violet and 
senescence was measured by SA-β-gal staining. D) mRNA levels of p15, p16, and p21 in 
sgTRRAP cells were measured by qRT-PCR and normalized to sgNT cells. Data was 
presented as mean ± SD; p-values were calculated by comparing to sgNT, *p < 0.05, **p < 
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Figure 3. Loss of histone acetyltransferase KAT5 impairs growth in HCC and 
induces senescence. A) Protein (left) and mRNA (right) levels of KAT2A and KAT5 
in Huh7 cells infected with sgNT and sgTRRAP as measured by western blot and 
qRT-PCR. B) Western blot of KAT2A, KAT5, and p21 levels in Huh7 cells infected 
with sgNT, sgKAT2A and sgKAT5.  C and D) Colony formation, senescence and cell 
growth of Huh7 cells infected with sgNT, sgKAT2A, and sgKAT5. C) Cells were 
stained with crystal violet and SA-β-gal. D) Cell growth was measured at 1, 3 and 5 
days after plating using the CTG assay and normalized to day 1. E) mRNA levels of 
p15, p16, and p21 in sgKAT2A and sgKAT5 cells were measured by qRT-PCR and 
normalized to sgNT cells. F) Tumor weight at day 30 (left) and tumor sizes (right) in 
nude mice subcutaneously injected with Huh7 cells. P-values were calculated using 
Mann-Whitney test against the sgNT group. Data was presented as mean ± SD; p-
values were calculated by comparing to sgNT, *p < 0.05, **p < 0.01, ***p < 0.001, NS 
= not significant (student’s t test).  
 
Figure 4. Senescence induced by TRRAP and KAT5 depletion is independent 
of p21. A) Schematic illustrating generation of p21 and TRRAP/KAT5 double 
knockout cells using CRISPR. B) Western blot analysis of TRRAP, KAT5 and p21 
levels in Huh7 and SNU-475 cells infected with the indicated sgRNAs. C) Colony 
formation and SA-β-gal staining of Huh7 cells infected with the indicated sgRNAs. 
NS = not significant (student’s t test).  
 
 
Figure 5. TRRAP/KAT5 activates transcription of mitotic genes and depletion 
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regulated genes in sgTRRAP cells compared to non-targeting control. The 10 most 
significant annotation clusters are shown here. B) Pipeline for identifying HCC-
relevant TRRAP target genes. C) GO analysis of the 22 TRRAP-activated genes 
identified in B. D) KAT5 binding analysis at the transcriptional start sites (TSS) of the 
22 TRRAP-activated genes using published ChIP-seq data (top). KAT5 binds to the 
TSS of TOP2A (bottom). E) mRNA levels of 6 TRRAP-activated genes in Huh7 cells 
infected with the indicated sgRNAs as measured by qRT-PCR. F) Cell cycle analysis 
of Huh7 infected with the indicated sgRNAs by BrdU and PI staining. Representative 
data (left) and quantification (right) are shown here. Data was presented as mean ± 
SD; p-values were calculated by comparing to non-targeting control, *p < 0.05, **p < 
0.01, ***p < 0.001 (student’s t test). 
 
Figure 6. Loss of TRRAP and KAT5 induce senescence through down-
regulation of TOP2A. A) Correlation between TRRAP and TOP2A mRNA 
expression in the TCGA HCC data set (n=360) was determined using Spearman’s 
correlation analysis (left). mRNA expression of TOP2A in non-tumor (N) and HCC 
(T) samples in the GSE14520 (second left) and TCGA HCC (second right) data sets, 
p-values were calculated using moderated t-test and the Wilcoxon signed-rank test 
respectively. Kaplan Meier curves of TCGA HCC patients with high or low TOP2A 
expression (right), p-value was calculated using the log-rank Mantel-Cox test. B) 
Protein levels of TOP2A and p21 in Huh7 cells infected with the indicated sgRNAs. 
C) Colony formation and SA-β-gal staining of Huh7 cells infected with sgTOP2A. D) 
mRNA levels of senescence markers p15, p16, and p21 in Huh7 cells infected with 
sgTOP2A. E) Cell cycle analysis of Huh7 cells infected with the indicated sgRNAs. 
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model. TRRAP and KAT5 induces HCC cell growth by activating expression of 
mitotic genes. Loss of TRRAP or KAT5 downregulate TOP2A, induce G2/M arrest 
and senescence. Data was presented as mean ± SD; p-values were calculated by 
comparing to non-targeting control, *p < 0.05, **p < 0.01, ***p < 0.001  (student’s t 
test). 
 
Table 1. List of genes that are down-regulated in the absence of TRRAP and 
identified from our bioinformatic analyses.  
 
Supplementary Figure 1. A kinome CRISPR screen identifies essential genes for 
HCC cell growth. A) mRNA levels of candidate genes in non-tumor and tumor 
samples in the GSE14520 data set. P-values were calculated using moderated t-
test. Black lines indicate the geometric mean of each group. B) Kaplan Meier curves 
of TCGA liver cancer patients with high or low expression of the candidate genes in 
A. P-values were calculated using the log-rank Mantel-Cox test. C) TRRAP mRNA 
up-regulation, copy-number alterations and/or mutations in TCGA patient HCC 
samples. D) Ingenuity Pathway analysis of genes that were positively correlated with 
TRRAP expression (Spearman’s correlation0.3) in TCGA HCC samples.  
 
Supplementary Figure 2. Loss of KAT5 impairs cell growth and induces 
senescence in HCC cells. A) Immunofluorescence images of Huh7 and SNU-475 
cells. B) Protein and mRNA levels of KAT2A and KAT5 in SNU-475 cells infected 
with sgNT and sgTRRAP. C) Huh7 cells were infected with the indicated sgRNAs, 
then treated with 2.5 μM MG132 or 50 μM chloroquine for 17 hours. Increased 
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proteasomal and lysosomal protein degradation. D) Western blot analysis of KAT2A, 
KAT5, and p21 levels in SNU-475 cells. E) Colony formation and SA-β-gal staining of 
SNU-475 cells. F) mRNA levels of p15, p16, and p21 in SNU-475 cells. Data was 
presented as mean ± SD; p-values were calculated by comparing to sgNT, *p < 0.05, 
**p < 0.01, ***p < 0.001  (student’s t test). 
 
Supplementary Figure 3. Identification of genes repressed by TRRAP. A) GO 
analysis of up-regulated genes in sgTRRAP cells compared to non-targeting control. 
The 10 most significant annotation clusters are shown here. B) Kaplan Meier curves 
of TCGA HCC patients with high or low expression of genes listed in Supplementary 
Table 3. C) Negative correlation between mRNA expression of TRRAP and TRRAP-
inhibited genes in the TCGA HCC data set (n=360). Correlation was determined 
using Spearman’s correlation analysis.  
 
Supplementary Figure 4. Increased expression of TRRAP-activated genes 
predicted poor prognosis in HCC patients. Kaplan Meier curves of TCGA HCC 
patients with high or low expression of TRRAP-activated genes listed in Table 1. P-
values were calculated using the log-rank Mantel-Cox test. The Kaplan Meier curve 
of BUB1B is shown in Supplementary Figure 1B.  
 
Supplementary Figure 5. Positive correlation between mRNA expression of 
TRRAP and TRRAP-activated genes. mRNA levels were downloaded from the 
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Supplementary Figure 6. KAT5 binds to the transcriptional start sites (TSS) of 
TRRAP-activated genes. Analysis of published ChIP-sequencing data for KAT5 
binding sites in mouse embryonic stem cells at TRRAP-activated genes (blue) 
identified in Table 1. Of note, no prominent peaks were observed at the TSS of 
Bub1b, Dlgap5 and Nsd2.  
 
Supplementary Figure 7. Depletion of TRRAP and KAT5 induce G2/M arrest 
without DNA damage. A) mRNA levels of TRRAP-activated genes in SNU-475 cells 
infected with the indicated sgRNAs compared to sgNT as measured by qRT-PCR. B) 
Cell cycle analysis of SNU-475 cells infected with the indicated sgRNAs by BrdU and 
PI staining. Representative data (left) and quantification (right) are shown here. C) 
Flow cytometry analysis of DNA damage in Huh7 cells using γH2A.X in the total cell 
population, 2N and >2N populations. DNA content was determined using PI staining. 
This experiment was repeated twice. Data was presented as mean ± SD; p-values 
were calculated by comparing to non-targeting control, *p < 0.05, **p < 0.01, ***p < 
0.001 (student’s t test). 
 
Supplementary Figure 8. TRRAP expression is not a predictor for prognosis in 
GBM. A) Correlation between TRRAP and TOP2A mRNA expression in the TCGA 
GBM data set (n=136) was determined using Spearman’s correlation analysis. B) 
Kaplan Meier curve of TCGA GBM patients with high (n=50) or low (n=51) TRRAP 
expression. P-value was calculated using the log-rank Mantel-Cox test.  
 
Supplementary Figure 9. Depletion of TOP2A induces G2/M arrest without DNA 
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indicated sgRNAs. B) Top2A promoter luciferase assay in 293fs cells transfected 
with the indicated plasmids. Luciferase activity was normalized to empty pBV-luc 
control. C) Colony formation and SA-β-gal staining of SNU-475 cells infected with 
sgTOP2A. D) mRNA levels of p15, p16, and p21 in SNU-475 cells infected with 
sgTOP2A.  E) Cell cycle analysis of SNU-475 cells infected with the indicated 
sgRNAs by BrdU and PI staining. Representative data (left) and quantification (right) 
are shown here. F) Flow cytometry analysis of DNA damage in Huh7 cells using 
γH2A.X in the total cell population, 2N and >2N populations. DNA content was 
determined using PI staining. This experiment was repeated twice. Data was 
presented as mean ± SD; p-values were calculated by comparing to non-targeting 
control, *p < 0.05, **p < 0.01, ***p < 0.001 (student’s t test). 
 
Supplementary Figure 10. p53 is more frequently mutated in high expressing 
TRRAP patient samples. p53 status in TRRAP high (n=115) and TRRAP low 
(n=118) TCGA HCC patient samples. P-value was calculated by Fisher’s exact test.  
 
Supplementary Table 1. sgRNA sequences used in this study.  
 
Supplementary Table 2. Primers used for qRT-PCR in this study.  
 
Supplementary Table 3. List of genes that are up-regulated in the absence of 
TRRAP and identified from our bioinformatics analyses.   
 
Supplementary Table 4. TRRAP regulates a similar set of genes in HCC and 
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identified in Table 1 in TCGA GBM patients (n=136). Genes in bold indicate a 
positive correlation with TRRAP expression (Spearman’s correlation > 0.3). 
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Table 1. List of genes that are down-regulated in the absence of TRRAP and identified from our bioinformatic analyses.  
 




TCGA HCC co-expressed 
with TRRAP 




ASPM Abnormal spindle microtubule 
assembly 
0.46 1.8E-02 8.22 8.3E-112 0.357 1.7E-11 
BUB1B BUB1 mitotic checkpoint 
serine/threonine kinase B 
0.42 2.6E-07 3.33 1.4E-73 0.428 2.0E-16 
CCNA2 Cyclin A2 0.35 2.2E-03 2.45 1.7E-59 0.309 9.8E-09 
CENPF Centromere protein F 0.39 5.7E-03 5.25 3.9E-101 0.452 2.3E-18 
DBF4 DBF4 zinc finger 0.46 8.4E-06 2.41 2.6E-71 0.48 7.2E-21 
DLGAP5 DLG associated protein 5 0.42 2.9E-06 2.49 6.9E-60 0.316 3.9E-09 
EZH2 Enhancer of zeste 2 polycomb 
repressive complex 2 subunit 
0.38 5.5E-07 3.41 2.4E-78 0.408 6.1E-15 
FOXM1 Forkhead box M1 0.38 4.5E-08 2.27 5.9E-67 0.414 2.2E-15 
KIF20A Kinesin family member 20A 0.23 1.2E-04 3.24 3.8E-80 0.332 5.9E-10 
KIF4A Kinesin family member 4A 0.41 5.5E-06 2.70 1.4E-69 0.314 5.3E-09 
MAD2L1 Mitotic arrest deficient 2 like 1 0.45 1.2E-06 2.88 4.9E-62 0.321 2.3E-09 
MCM2 Minichromosome maintenance 
complex component 2 
0.38 1.9E-07 3.13 6.3E-69 0.342 1.5E-10 
MCM4 Minichromosome maintenance 
complex component 4 
0.46 1.0E-06 3.03 3.2E-72 0.53 5.9E-26 
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NSD2 Nuclear receptor binding SET 
domain protein 2 
0.46 3.5E-06 2.10 3.0E-61 0.605 2.6E-35 
PRC1 Protein regulator of cytokinesis 1 0.40 4.9E-09 5.49 9.2E-106 0.378 8.2E-13 
RACGAP1 Rac gtpase activating protein 1 0.39 1.2E-07 4.66 2.5E-108 0.333 5.1E-10 
RAD51AP1 RAD51 associated protein 1 0.50 3.3E-04 2.59 2.0E-62 0.411 4.1E-15 
TOP2A DNA topoisomerase II alpha 0.34 5.2E-03 8.27 8.5E-98 0.406 8.6E-15 
TPX2 TPX2, microtubule nucleation 
factor 
0.37 5.6E-08 3.22 7.3E-71 0.317 3.6E-09 
TTK TTK protein kinase 0.47 2.0E-05 3.22 9.7E-69 0.306 1.4E-08 
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